[Peritoneal dialysis versus hemodialysis for end stage renal disease]

Tapia López E, García Martí S, Mengarelli C, Pichon-Riviere A, Augustovski F, Alcaraz A, Bardach A, Ciapponi A.
Record ID 32018001401
Spanish
Original Title: Diálisis peritoneal versus hemodiálisis en enfermedad renal crónica – estadio 5
Authors' recommendations: CONCLUSIONS Moderate quality evidence suggests that peritoneal dialysis, in patients with end stage renal disease not eligible for hemodialysis, offers clinical benefits comparable to those of hemodialysis. Moderate quality evidence suggests that in patients with end stage renal disease, peritoneal dialysis is at least as effective as hemodialysis in reducing mortality for any cause and cardiovascular mortality and it also reduces the risk of developing congestive heart failure when compared with hemodialysis. The assessment of other parameters such as ferritin, transferrin saturation index, parathyroid hormone and quality of life did not show significant differences between both types of dialysis. The clinical practice guidelines consider both types of dialysis as treatment alternatives in patients with end stage renal disease taking into account that both have advantages and disadvantages. The public and private health sponsors consulted cover both alternatives.
Details
Project Status: Completed
Year Published: 2017
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Renal Dialysis
  • Dialysis
  • Peritoneal Dialysis
  • Kidney Failure, Chronic
  • Renal Insufficiency, Chronic
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.